Orange is one of the world’s leading telecommunications operators with sales of €41 billion in 2018 and 151,000 employees worldwide at 31 December 2018, including 92,000 employees in France. The g roup has a total customer base of 264 million customers worldwide at 31 December 2018, including 204 million mobile customers and 20 million fixed broadband customers. The Group is present in 27 countries. Orange is also a leading provider of global IT and telecommunication services to multinational companies, under the brand Orange Business Services.

In addition to reshaping societies, digital technology is opening up new growth opportunities for Orange. The overarching aim of the company is to build a more intelligent, more open and more responsible society. That involves rising to the challenges that the digital revolution is bringing about, i.e. harnessing innovation to make it useful and make sure its benefits reach as many people as possible.

Gavi and Orange Middle East and Africa recognise the importance of mobile health solutions to improve the efficiency of national health systems, especially in reaching the millions of children who continue to miss out on life-saving vaccines that protect them for life.

In 2018, Gavi, the Cote d’Ivoire Ministry of Health and Orange Cote d’Ivoire signed a three-way partnership agreement to design and implement ‘mVaccin,’ a cell phone application to help health agents collect data to create personal ised electronic immun isation schedules and conduct a more custom ised and timely follow-up of the mother/child pair to reduce dropouts. The solution is currently deployed in the high-priority health districts and has also been leveraged for the COVID-19 response.

Gavi is also working closely with Orange in Sierra Leone to provide off-grid renewable electricity generation and storage systems and Internet connectivity to rural health facilities that are not covered by the country’ s current CCEOP. By strengthening rural health facility capacity, bringing in power, connectivity, and purified water, the project aims to increase the operational capacity of health facilities, facilitate data connectivity, improve the community level appreciation of health facilities, and ensure greater util isation of immun isation and primary health care services.

This concept, developed by Power Africa Sierra Leone, Orange, and Gavi, focuses on testing, refining, and ultimately proving a low-cost, high-impact replication methodology for delivering MicroUtilities to remote rural health facilities through a public-private partnership. The MicroUtilities project received extensive and high-level visibility from USAID, which has invited Gavi to join the newly created Healthcare Electrification and Telecommunication Alliance (HETA), which will enhance health services and assist in COVID-19 response efforts by providing reliable, renewable, and affordable electricity in healthcare facilities across sub-Saharan Africa. This catalytic global infrastructure initiative, inspired by the Sierra Leone Gavi- Orange- USAID - MoH partnership, was announced by President Biden at the Carbis Bay G7 Summit.

For more information about Orange, please visit https://healthcare.orange.com/en/

Orange healthcare

Orange

 

PROCEEDS TO GAVI FROM DONOR CONTRIBUTIONS & PLEDGES (2021-2025) AS OF 30 June 2022

Proceeds are funds made available to Gavi from donor contributions and commitments, either through cash payments made to Gavi, through frontloading via the capital markets of a future donor commitment to IFFIm, or through AMC funds released to Gavi via the World Bank. IFFIm proceeds are allocated over five-year periods coinciding with Gavi’s strategic periods. Proceeds for the current and future strategic periods are indicative until the end of each period and could be revised following changes in market conditions (interest rates or foreign exchange rates), the signing of new pledge(s) and/or changes in IFFIm’s disbursement profile.

Contributions and pledges over time (US$ Millions)

Click on Direct, IFFIm, AMC or Matching Fund in the above key to toggle their data on the graph, click again to show the data

Notes:
Direct Contributions (including Matching Fund)

Received contributions: non-US$ contributions for 2000-2021 and Q1-Q2 2022 are expressed in US$ equivalents using the exchange rates on the dates of receipt. For 2014-2021 and Q1-Q2 2022 where contributions were hedged to mitigate currency risk exposure, these have been expressed using the rates applicable to the hedge agreement.

Future contributions (for pledges made prior to the June 2020 donor pledging conference): non-US$ Direct Contribution and Matching Fund pledges for Q3-Q4 2022 and for years 2023 and beyond are expressed in US$ equivalents using the applicable forecast rates from Bloomberg as at 30 June 2022 or using the rates applicable to any hedge agreement in place.

Future contributions (for pledges at the June 2020 donor pledging conference): non-US$ Direct Contribution and Matching Fund pledges for Q3-Q4 2022 and for years 2023 and beyond are expressed in US$ equivalents using the spot rates from Bloomberg as at 30 June 2022 or using the rates applicable to any hedge agreement in place.

IFFIm contributions

Received contributions: non-US$ contributions for 2000-2021 and Q1-Q2 2022 are expressed in US$ equivalents as confirmed by the IBRD (World Bank)

Future contributions: non-US$ contributions for Q3-Q4 2022 and for years 2023 and beyond are expressed in US$ equivalents as follows:

  • - For signed contribution agreements: contributions are expressed in US$ equivalents using the exchange rates at the time of signing the respective donor grant agreements.

  • - For contribution agreements not yet signed: contributions are expressed in US$ equivalents using the applicable spot rates from Bloomberg as at 30 June 2022.

Due to IFFIm’s nature as a frontloading vehicle, yearly contributions paid into IFFIm can differ significantly from yearly proceeds transferred to Gavi.

While IFFIm grants are irrevocable and legally binding, they are subject to a Grant Payment Condition that can potentially reduce the amount due by the donor in the event that a Gavi-supported programme country is in protracted arrears with the International Monetary Fund. As of 29 June 2021, there is no longer any reduction applied, as all countries from the reference portfolio have cleared their arrears with the IMF.


All donors

Subscribe to our newsletter